Pfizer’s Lyrica Is “Approvable” At FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Neurontin follow-on drug pregabalin receives second “approvable” decision in two months. Pfizer is looking to convert Neurontin patients to the successor product in the face of gabapentin generics.